PT70882A - Preparation process of new pyrimidine derivatives - Google Patents

Preparation process of new pyrimidine derivatives

Info

Publication number
PT70882A
PT70882A PT70882A PT7088280A PT70882A PT 70882 A PT70882 A PT 70882A PT 70882 A PT70882 A PT 70882A PT 7088280 A PT7088280 A PT 7088280A PT 70882 A PT70882 A PT 70882A
Authority
PT
Portugal
Prior art keywords
preparation process
pyrimidine derivatives
new pyrimidine
new
derivatives
Prior art date
Application number
PT70882A
Other languages
English (en)
Portuguese (pt)
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT70882(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of PT70882A publication Critical patent/PT70882A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT70882A 1979-03-10 1980-02-29 Preparation process of new pyrimidine derivatives PT70882A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7914987 1979-04-30

Publications (1)

Publication Number Publication Date
PT70882A true PT70882A (en) 1980-03-01

Family

ID=26270867

Family Applications (1)

Application Number Title Priority Date Filing Date
PT70882A PT70882A (en) 1979-03-10 1980-02-29 Preparation process of new pyrimidine derivatives

Country Status (24)

Country Link
JP (1) JPS55122768A (US06623731-20030923-C00052.png)
AR (1) AR222691A1 (US06623731-20030923-C00052.png)
AU (1) AU533547B2 (US06623731-20030923-C00052.png)
BE (1) BE881752A (US06623731-20030923-C00052.png)
CA (1) CA1132561A (US06623731-20030923-C00052.png)
CH (1) CH644368A5 (US06623731-20030923-C00052.png)
DE (3) DE3050999C2 (US06623731-20030923-C00052.png)
EG (1) EG14282A (US06623731-20030923-C00052.png)
FI (1) FI66357C (US06623731-20030923-C00052.png)
FR (2) FR2451370A1 (US06623731-20030923-C00052.png)
GB (1) GB2045756B (US06623731-20030923-C00052.png)
HK (1) HK55383A (US06623731-20030923-C00052.png)
IE (1) IE49547B1 (US06623731-20030923-C00052.png)
IN (1) IN153791B (US06623731-20030923-C00052.png)
LU (1) LU82185A1 (US06623731-20030923-C00052.png)
MX (1) MX6218E (US06623731-20030923-C00052.png)
MY (1) MY8400200A (US06623731-20030923-C00052.png)
NL (1) NL184833C (US06623731-20030923-C00052.png)
NO (1) NO154054C (US06623731-20030923-C00052.png)
NZ (1) NZ192927A (US06623731-20030923-C00052.png)
OA (1) OA06484A (US06623731-20030923-C00052.png)
PT (1) PT70882A (US06623731-20030923-C00052.png)
SE (1) SE435180B (US06623731-20030923-C00052.png)
SG (1) SG22683G (US06623731-20030923-C00052.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Also Published As

Publication number Publication date
NZ192927A (en) 1981-07-13
FR2451370B1 (US06623731-20030923-C00052.png) 1983-05-13
NL8001289A (nl) 1980-09-12
FI66357C (fi) 1984-10-10
AU533547B2 (en) 1983-12-01
MX6218E (es) 1984-12-21
NO800664L (no) 1980-09-11
DE3016752C2 (US06623731-20030923-C00052.png) 1987-06-25
EG14282A (en) 1983-09-30
NO154054B (no) 1986-04-01
IE49547B1 (en) 1985-10-30
CH644368A5 (en) 1984-07-31
AU5624880A (en) 1980-09-18
DE3009071C2 (de) 1985-11-14
NL184833B (nl) 1989-06-16
CA1132561A (en) 1982-09-28
GB2045756A (en) 1980-11-05
NL184468B (nl) 1989-03-01
NL184833C (nl) 1989-11-16
HK55383A (en) 1983-11-25
NO154054C (no) 1986-07-09
LU82185A1 (fr) 1980-06-06
AR222691A1 (es) 1981-06-15
OA06484A (fr) 1981-07-31
JPS55122768A (en) 1980-09-20
GB2045756B (en) 1983-01-26
DE3016752A1 (de) 1980-12-04
IN153791B (US06623731-20030923-C00052.png) 1984-08-18
FR2451191A1 (fr) 1980-10-10
FI66357B (fi) 1984-06-29
DE3050999A1 (US06623731-20030923-C00052.png) 1985-08-14
SE8001812L (sv) 1980-09-11
MY8400200A (en) 1984-12-31
FR2451191B1 (US06623731-20030923-C00052.png) 1983-04-29
BE881752A (fr) 1980-05-30
IE800477L (en) 1980-09-10
SE435180B (sv) 1984-09-10
FR2451370A1 (fr) 1980-10-10
JPS6126996B2 (US06623731-20030923-C00052.png) 1986-06-23
FI800566A (fi) 1980-09-11
SG22683G (en) 1983-12-16
DE3050999C2 (de) 1986-08-14
DE3009071A1 (de) 1980-09-11

Similar Documents

Publication Publication Date Title
PT72079A (en) Process for the preparation of 7-acylamino-3-vinylcephalosporanic acid derivatives
GR62452B (en) Preparation process of guanidine derivatives
YU67183A (en) Process for obtaining new derivatives of 6-beta-hydroxyalkyl penicillinates
RO83052B (ro) Procedeu pentru prepararea unor derivati de fenetanolamina
PT71251A (en) Process for preparation of pyrimidin compounds
NZ192948A (en) Preparation of beta-trifuloromethyl-pyridine derivatives directly from beta-picoline
PT70882A (en) Preparation process of new pyrimidine derivatives
YU136880A (en) Process for obtaining new derivatives of 3-vinyl-cephalosporin
GR62466B (en) Preparation process of new optionally racemic pyrimidine derivatives
EG13294A (en) Process for preparing of s-triazolo-(1,5-a)pyrimidine derivatives
DE3063952D1 (en) Process for the preparation of riboflavin
DE3064993D1 (en) Process for the preparation of hexahydronaphthacene derivatives
RO85323B (ro) Procedeu pentru prepararea unor fenoxiamine heterociclice
PH22005A (en) Process for the preparation of new hemoserine derivatives
PT71582A (en) Process for the preparation of 3-methyleneazetidine derivatives
GR61726B (en) Preparation process of novel isoquinoleine derivatives
PT71031A (en) Process for the preparation of benzodiazepine derivatives
PT70716A (en) Process for the preparation of novel spiro-quinolylhydantoin derivatives
IL60862A0 (en) Preparation of pyrimidine derivatives
YU42987B (en) Process for preparing new derivatives of 1-oxadethiacephalosporin
GB2041915B (en) Preparation of bromo-p-terphenyl derivatives
EG14260A (en) Preparation process of new halogeno derivatives of isopropylamino pyrimidine
YU43123B (en) Process for obtaining substituted derivatives of acylcarbamides
JPS55145671A (en) Manufacture of pyrimidine
GB2047243B (en) Preparing derivatives of 6 - amidino - penicillanic acid